Lung cancer | |
---|---|
Other names | Lung carcinoma |
A chest X-ray showing a tumor in the lung (marked by arrow) | |
Specialty | Oncology, pulmonology |
Symptoms | Coughing (including coughing up blood), shortness of breath, chest pain |
Usual onset | After age 40;[1] 70 years on average[2] |
Types | Small-cell lung carcinoma (SCLC), non-small-cell lung carcinoma (NSCLC) |
Risk factors |
|
Diagnostic method | Medical imaging, tissue biopsy |
Prevention | Avoid smoking and other environmental mutagens |
Treatment | Surgery, chemotherapy, radiotherapy, molecular therapies, immune checkpoint inhibitors |
Prognosis | Five-year survival rate: 10 to 20% (most countries)[3] |
Frequency | 2.2 million (2020)[3] |
Deaths | 1.8 million (2020)[3] |
Lung cancer | |
---|---|
Other names | Lung carcinoma |
A chest X-ray showing a tumor in the lung (marked by arrow) | |
Specialty | Oncology, pulmonology |
Symptoms | Coughing (including coughing up blood), shortness of breath, chest pain |
Usual onset | After age 40;[1] 70 years on average[2] |
Types | Small-cell lung carcinoma (SCLC), non-small-cell lung carcinoma (NSCLC) |
Risk factors |
|
Diagnostic method | Medical imaging, tissue biopsy |
Prevention | Avoid smoking and other environmental mutagens |
Treatment | Surgery, chemotherapy, radiotherapy, molecular therapies, immune checkpoint inhibitors |
Prognosis | Five-year survival rate: 10 to 20% (most countries)[3] |
Frequency | 2.2 million (2020)[3] |
Deaths | 1.8 million (2020)[3] |